Image

Study of VGA039 in Healthy Volunteers and Patients with Von Willebrand Disease (VIVID)

Study of VGA039 in healthy people and Von Willebrand Disease patients.

Recruiting
12-60 years
All
Phase 1/2
  • Simplified description (AI rewritten)
  • Technical description (Original)

The VIVID study tests a new drug, VGA039, for people with Von Willebrand Disease (VWD), a bleeding disorder where blood doesn’t clot well. The study has five parts and involves healthy volunteers and people with VWD. Some people will get the drug through a needle in their vein (IV) or under their skin (SC). Parts of the study are double-blind, meaning neither the doctor nor the participant knows if they are getting the drug or a placebo (a fake treatment). Other parts are open-label, where everyone knows the participant gets the real drug. Participation lasts 8 to 15 weeks. To join, you must be 12 to 60 years old, and have no serious health issues. If you have VWD, you should have symptoms like bleeding or bruising. You cannot join if you have certain blood disorders or have used hormonal contraceptives recently.

  • Study lasts 8 to 15 weeks.
  • No serious health issues needed.
  • Involves injections (IV or SC).
Print
Study details
    Von Willebrand Diseases

NCT05776069

Vega Therapeutics, Inc

6 April 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.